Navidea Biopharmaceuticals (NAVB) Retains Stern IR for Investor Relations Services  
4/5/2013 9:49:46 AM

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, announced today that it has retained Stern Investor Relations, Inc. to provide strategic advisory services and execute and enhance the Company’s investor relations program. Stern IR is a full service investor relations firm specializing in entrepreneurial healthcare and biotechnology companies.